Andre T, Shiu KK, Kim TW, Jensen BV, et al. Pembrolizumab Versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase 3 KEYNOTE-177 study. Ann Oncol 2024 Dec 2:S0923-7534(24)04949-4. doi: 10.1016/j.annonc.2024.
PMID: 39631622